Skip to main content
. 2022 Apr 21;47:101409. doi: 10.1016/j.eclinm.2022.101409

Table 1.

Summary of patients discharged over time (modified intention-to-treat population).

Patients discharged, n (%) Tocilizumab N = 294
Placebo N = 144
Weekly Cumulative Weekly Cumulative
Day 7 55 (18·7) 55 (18·7) 19 (13·2) 19 (13·2)
Day 14 58 (19·7) 113 (38·4) 24 (16·7) 43 (29·9)
Day 21 28 (9·5) 141 (48·0) 16 (11·1) 59 (41·0)
Day 28 16 (5·4) 157 (53·4) 7 (4·9) 66 (45·8)
Day 35 9 (3·1) 166 (56·5) 7 (4·9) 73 (50·7)
Day 45 15 (5·1) 181 (61·6) 13 (9·0) 86 (59·7)
Day 60 16 (5·4) 197 (67·0) 6 (4·2) 92 (63·9)

Only first discharge is shown. Patients who were readmitted to hospital within 12 h were not counted as discharged.